BRIC Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: July 09, 2025 Report Code: GDME20428CRDB-ST

Select Item

GlobalData’s “BRIC Metabolic Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the BRIC Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Diabetes Assays and Cholesterol Tests

The BRIC Metabolic Disorders Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Metabolic Disorders Market.
• Global corporate-level profiles of key companies operating within the BRIC Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

BRIC Metabolic Disorders is segmented as follows –

• Diabetes Assays

• Cholesterol Tests

Reasons to Buy

The BRIC Metabolic Disorders Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories
Alfa Wassermann Inc
ALPCO Diagnostics
Beckman Coulter Inc
Bio-Rad Laboratories Inc
Danaher Corp
DiaSorin SpA
EKF-diagnostic GmbH

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Metabolic Disorders Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Metabolic Disorders Market, BRIC 10

3.1 Metabolic Disorders Market, BRIC, Revenue ($m), 2018-2033 10

3.2 Metabolic Disorders Market, BRIC, Revenue ($m), 2018-2033 11

3.3 Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 13

3.4 Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 14

3.5 Metabolic Disorders Market, BRIC, Company Share by Revenue ($m), 2024 16

4 Metabolic Disorders Market, China 18

4.1 Metabolic Disorders Market, China, Revenue ($m), 2018-2033 18

4.1.1 Cholesterol Tests Market, China, Revenue ($m), by Segment, 2018-2033 20

4.1.2 Diabetes Assays Market, China, Revenue ($m), by Segment, 2018-2033 22

4.2 Metabolic Disorders Market, China, Volume (Units), 2018-2033 24

4.2.1 Cholesterol Tests Market, China, Volume (Units), by Segment, 2018-2033 26

4.2.2 Diabetes Assays Market, China, Volume (Units), by Segment, 2018-2033 29

4.3 Metabolic Disorders Market, China, Average Price ($), 2018-2033 32

4.4 Metabolic Disorders Market, China, Company Share by Revenue ($m), 2024 33

5 Metabolic Disorders Market, Russia 35

5.1 Metabolic Disorders Market, Russia, Revenue ($m), 2018-2033 35

5.1.1 Cholesterol Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 37

5.1.2 Diabetes Assays Market, Russia, Revenue ($m), by Segment, 2018-2033 39

5.2 Metabolic Disorders Market, Russia, Volume (Units), 2018-2033 41

5.2.1 Cholesterol Tests Market, Russia, Volume (Units), by Segment, 2018-2033 43

5.2.2 Diabetes Assays Market, Russia, Volume (Units), by Segment, 2018-2033 46

5.3 Metabolic Disorders Market, Russia, Average Price ($), 2018-2033 48

5.4 Metabolic Disorders Market, Russia, Company Share by Revenue ($m), 2024 49

6 Metabolic Disorders Market, India 51

6.1 Metabolic Disorders Market, India, Revenue ($m), 2018-2033 51

6.1.1 Cholesterol Tests Market, India, Revenue ($m), by Segment, 2018-2033 53

6.1.2 Diabetes Assays Market, India, Revenue ($m), by Segment, 2018-2033 55

6.2 Metabolic Disorders Market, India, Volume (Units), 2018-2033 57

6.2.1 Cholesterol Tests Market, India, Volume (Units), by Segment, 2018-2033 59

6.2.2 Diabetes Assays Market, India, Volume (Units), by Segment, 2018-2033 62

6.3 Metabolic Disorders Market, India, Average Price ($), 2018-2033 65

6.4 Metabolic Disorders Market, India, Company Share by Revenue ($m), 2024 66

7 Metabolic Disorders Market, Brazil 68

7.1 Metabolic Disorders Market, Brazil, Revenue ($m), 2018-2033 68

7.1.1 Cholesterol Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 70

7.1.2 Diabetes Assays Market, Brazil, Revenue ($m), by Segment, 2018-2033 72

7.2 Metabolic Disorders Market, Brazil, Volume (Units), 2018-2033 74

7.2.1 Cholesterol Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 76

7.2.2 Diabetes Assays Market, Brazil, Volume (Units), by Segment, 2018-2033 79

7.3 Metabolic Disorders Market, Brazil, Average Price ($), 2018-2033 81

7.4 Metabolic Disorders Market, Brazil, Company Share by Revenue ($m), 2024 82

8 Overview of Key Companies in Asia-Pacific Metabolic Disorders Market 84

8.1 Roche Diagnostics International Ltd 84

8.1.1 Company Overview 84

8.2 Siemens Healthineers AG 84

8.2.1 Company Overview 84

8.3 Beckman Coulter Inc 84

8.3.1 Company Overview 84

8.4 Abbott Laboratories 85

8.4.1 Company Overview 85

9 Metabolic Disorders Market Pipeline Products 86

10 Appendix 87

10.1 Research Methodology 88

10.1.1 Coverage 88

10.1.2 Secondary Research 88

10.1.3 Primary Research 88

10.1.4 Market Modeling and Forecasting 89

10.1.5 Company Share Analysis 90

10.1.6 Benchmarking 91

10.2 GlobalData Consulting 92

10.3 Contact Us 92

10.4 Disclaimer 92

Table

Table 1: Metabolic Disorders Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Metabolic Disorders Market, BRIC, Revenue ($m), USD Constant, 2018-2033 12

Table 3: Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 13

Table 4: Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 15

Table 5: Metabolic Disorders Market, BRIC, Company Share by Revenue ($m), 2024 17

Table 6: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2018-2033 19

Table 7: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2018-2033 21

Table 8: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2018-2033 23

Table 9: Metabolic Disorders Market, China, Volume (Units), 2018-2033 25

Table 10: Cholesterol Tests Market, China, Volume (Units), 2018-2033 27

Table 11: Diabetes Assays Market, China, Volume (Units), 2018-2033 30

Table 12: Metabolic Disorders Market, China, Average Price ($), 2018-2033 32

Table 13: Metabolic Disorders Market, China, Company Share by Revenue ($m), 2024 34

Table 14: Metabolic Disorders Market, Russia, Revenue ($m), USD Constant, 2018-2033 36

Table 15: Cholesterol Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 38

Table 16: Diabetes Assays Market, Russia, Revenue ($m), USD Constant, 2018-2033 40

Table 17: Metabolic Disorders Market, Russia, Volume (Units), 2018-2033 42

Table 18: Cholesterol Tests Market, Russia, Volume (Units), 2018-2033 44

Table 19: Diabetes Assays Market, Russia, Volume (Units), 2018-2033 47

Table 20: Metabolic Disorders Market, Russia, Average Price ($), 2018-2033 48

Table 21: Metabolic Disorders Market, Russia, Company Share by Revenue ($m), 2024 50

Table 22: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2018-2033 52

Table 23: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2018-2033 54

Table 24: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2018-2033 56

Table 25: Metabolic Disorders Market, India, Volume (Units), 2018-2033 58

Table 26: Cholesterol Tests Market, India, Volume (Units), 2018-2033 60

Table 27: Diabetes Assays Market, India, Volume (Units), 2018-2033 63

Table 28: Metabolic Disorders Market, India, Average Price ($), 2018-2033 65

Table 29: Metabolic Disorders Market, India, Company Share by Revenue ($m), 2024 67

Table 30: Metabolic Disorders Market, Brazil, Revenue ($m), USD Constant, 2018-2033 69

Table 31: Cholesterol Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 71

Table 32: Diabetes Assays Market, Brazil, Revenue ($m), USD Constant, 2018-2033 73

Table 33: Metabolic Disorders Market, Brazil, Volume (Units), 2018-2033 75

Table 34: Cholesterol Tests Market, Brazil, Volume (Units), 2018-2033 77

Table 35: Diabetes Assays Market, Brazil, Volume (Units), 2018-2033 80

Table 36: Metabolic Disorders Market, Brazil, Average Price ($), 2018-2033 81

Table 37: Metabolic Disorders Market, Brazil, Company Share by Revenue ($m), 2024 83

Table 38: Metabolic Disorders Market Pipeline Products 86

Table 39: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 89

Figures

Figure 1: Metabolic Disorders Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Metabolic Disorders Market, BRIC, Revenue ($m), USD Constant, 2018-2033 11

Figure 3: Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 13

Figure 4: Metabolic Disorders Market, BRIC, Volume (Units), 2018-2033 14

Figure 5: Metabolic Disorders Market, BRIC, Company Share (%), 2024 16

Figure 6: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2018-2033 18

Figure 7: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2018-2033 20

Figure 8: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2018-2033 22

Figure 9: Metabolic Disorders Market, China, Volume (Units), 2018-2033 24

Figure 10: Cholesterol Tests Market, China, Volume (Units), 2018-2033 26

Figure 11: Diabetes Assays Market, China, Volume (Units), 2018-2033 29

Figure 12: Metabolic Disorders Market, China, Company Share (%), 2024 33

Figure 13: Metabolic Disorders Market, Russia, Revenue ($m), USD Constant, 2018-2033 35

Figure 14: Cholesterol Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 37

Figure 15: Diabetes Assays Market, Russia, Revenue ($m), USD Constant, 2018-2033 39

Figure 16: Metabolic Disorders Market, Russia, Volume (Units), 2018-2033 41

Figure 17: Cholesterol Tests Market, Russia, Volume (Units), 2018-2033 43

Figure 18: Diabetes Assays Market, Russia, Volume (Units), 2018-2033 46

Figure 19: Metabolic Disorders Market, Russia, Company Share (%), 2024 49

Figure 20: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2018-2033 51

Figure 21: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2018-2033 53

Figure 22: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2018-2033 55

Figure 23: Metabolic Disorders Market, India, Volume (Units), 2018-2033 57

Figure 24: Cholesterol Tests Market, India, Volume (Units), 2018-2033 59

Figure 25: Diabetes Assays Market, India, Volume (Units), 2018-2033 62

Figure 26: Metabolic Disorders Market, India, Company Share (%), 2024 66

Figure 27: Metabolic Disorders Market, Brazil, Revenue ($m), USD Constant, 2018-2033 68

Figure 28: Cholesterol Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 70

Figure 29: Diabetes Assays Market, Brazil, Revenue ($m), USD Constant, 2018-2033 72

Figure 30: Metabolic Disorders Market, Brazil, Volume (Units), 2018-2033 74

Figure 31: Cholesterol Tests Market, Brazil, Volume (Units), 2018-2033 76

Figure 32: Diabetes Assays Market, Brazil, Volume (Units), 2018-2033 79

Figure 33: Metabolic Disorders Market, Brazil, Company Share (%), 2024 82

BRIC Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at BRIC Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests in real time.

  • Access a live BRIC Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more